Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Medical device company, Osteopore (OSX) is continuing its sales momentum, despite the COVID-19 pandemic
  • The company is seeing strong sales of its 3D ‘bone healing’ implants at its Singapore manufacturing facility
  • Sales for the first quarter of 2020 are approximately $313,000, a 60 per cent improvement over the first quarter sales in 2019
  • Osteopore is up 8.86 per cent on the market, selling shares for 43¢ each

Medical device company, Osteopore (OSX) is continuing its sales momentum, despite the COVID-19 pandemic.

The company is seeing strong sales of its 3D ‘bone healing’ implants at its Singapore manufacturing facility.

Sales for the first quarter of 2020 are approximately $313,000, a 60 per cent improvement over the first quarter sales in 2019.

Osteopore specialises in the production of bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing.

CEO Goh Khoon Seng says these results show of the increasing demand of the company’s unique 3D implants.

“Osteopore is also pleased to confirm that it has been included as an “essential service” and will, therefore, continue to be opened and operational during Singapore’s shut down of all schools and most workplaces to stem the spike of local COVID-19 cases,” Goh said.

“Osteopore shall implement the Enhanced Business Continuity Plan (BCP) to maintain operations with only essential staff,” he added.

The company reported it has a strong cash balance of $3.3 million (as of December 31) and says it is well placed to continue the momentum in 2020.

“Despite these challenging times, Osteopore is continuing to progress key business development initiatives,” Chairman Brett Sandercock said.

“We are committed to ensuring the safety of all our staff, customers and suppliers and will continue to monitor the impact of the COVID-19 pandemic on all aspects of the business,” he added.

Osteopore is up 8.86 per cent on the market, selling shares for 43¢ each at market close.

OSX by the numbers
More From The Market Herald
The Market Herald Video

" Proteomics International Laboratories (ASX:PIQ) signs binding LOI with Sonic Healthcare USA

Proteomics International Laboratories (ASX:PIQ) signs a binding letter of intent to introduce PromarkerD to the US.
The Market Herald Video

" Dimerix (ASX:DXB) submits new patent family application for DMX-700

Dimerix (ASX:DXB) has submitted a new patent family application for its flagship DMX-700 used to treat…
The Market Herald Video

" Mesoblast (ASX:MSB) raises US$45m for lead products

Mesoblast (ASX:MSB) completes its private placement which raised US$45 million (A$64.5 million).
The Market Herald Video

" Imugene (ASX:IMU) sees “positive signs” from lung cancer trial, presents data at 2022 world conference

Imugene (ASX:IMU) presents new data from its PD1-Vaxx trial in non-small cell lung cancer patients at…